Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Colorectal Cancer

Breast Cancer

Gastrointestinal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Colorectal Cancer

Research Efforts Poised to Redefine Role of Immunotherapy in mCRC

Neil H. Segal, MD, PhD, discusses the current role of immunotherapy in colorectal cancer and the work being done to define its role in earlier-line settings and among patients with microsatellite stable disease.
Read More >>

Ongoing Studies May Clarify Role of ADCs in Gastric Cancer and CRC

GI 2020: Regorafenib/TAS-102 Induces Clinically Meaningful DCR in Refractory Metastatic CRC

GI 2020: High Responses Observed With Avelumab Added to Regimen for Metastatic Colorectal Cancer Does Not Translate to PFS

GI 2020: Kopetz Highlights Improved QoL, Efficacy With Encorafenib Regimens in BRAF+ mCRC

Investigators Test Breakthrough-Designated Triplet in First-Line CRC

View More Stories >>

View Conference Coverage

2020 Transplantation & Cellular Therapy Meetings

2020 Winter Lung Cancer Conference

2020 Genitourinary Cancers Symposium

2020 SGO Winter Meeting

2020 Gastrointestinal Cancers Symposium

Dr. Kopetz on the Rationale and Design of the BEACON CRC Study in mCRC

Dr. Eng on Increasing Awareness for Adolescents/Young Adults With CRC

Dr. Lockhart on Dual-Immunotherapy Strategies in CRC

Dr. Cercek on the Importance of Molecular Testing in CRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Future Directions in I/O Therapy for mCRC

Immunotherapy in CRC

New Therapy Options for BRAF-Mutated mCRC

Management of Colorectal Cancer Metastases

TRIBE-2: FOLFOX or FOLFIRI With Bevacizumab in mCRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Molecular Testing for Metastatic CRC in 2020

Novel Therapies for BRAF+ Colorectal Cancer

Treating BRAF+ Colorectal Cancer

Targeting BRAF and MEK in Colorectal Cancer

Ongoing Treatment & Approach Advancements in mCRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Treatment Goals in Refractory mCRC

$Treatment Goals in Refractory mCRC$
Tanios Bekaii-Saab, MD, FACP, Andrea Cercek, MD, and Zev A. Wainberg, MD, provide insight to the treatment goals for patients with refractory metastatic colorectal cancer.

View Now

Therapeutic Strategies in Metastatic Colorectal Cancer

Recent advances in the treatment of metastatic colorectal cancer (mCRC) have improved survival. However, many questions remain. Led by John L. Marshall, MD, panelists Tanios Bekaii-Saab, MD; Johanna Bendell, MD; Richard Kim, MD; and Charles S. Fuchs, MD, MPH, discuss strategies and approaches to managing mCRC, including the latest research and how it may influence clinical practice.

View Now

Featured Video

Dr. Marshall on Physician Burnout in Oncology

John L. Marshall, MD, of Medstar Georgetown University Hospital, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer, Georgetown-Lombardi Comprehensive Cancer Center, discusses physician burnout in oncology. View now

OncLive News Network On Location: GU 2020 Day 3